The second edition of ETPharma’s Next-Gen LabCon will focus on the seamless progression of a product life cycle, heightened competition and building next-gen, future-ready pharma labs, which are crucial to fulfilling the demand for innovative therapies, enhancing approval rates, minimising expenses, accelerating time-to-market, and adhering to regulatory obligations.
Source – ETHealth World
